Senior insider sale
Chief Scientific Officer at CARISMA THERAPEUTICS INC. — senior position signals high conviction
$134.2K
484.35K shares
What this filing means
KLICHINSKY MICHAEL plans to sell 484.35K shares of CARISMA THERAPEUTICS INC. valued at approximately $134.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/30/2025ACC: 0001104659-25-095177
Officer· Chief Scientific Officer
Since Mar 2023
484.35K
Shares to sell
$134.2K
Approx. market value
484.35K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founder Stock
Compensation
5/31/2017
484.35KTotal acquired484.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/31/2017 | Founder Stock Compensation | 484.35K | — |
| Total | 484.35K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
484.35K
Market value
$134.2K
9/30/2025
Total
Units
484.35K
Value
$134.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/30/2025 | 484.35K | $134.2K | NASDAQ | Planned |
| Total | 484.35K | $134.2K | ||